Ken Griffin Oncolytics Biotech Inc Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 137,085 shares of ONCY stock, worth $135,714. This represents 0.0% of its overall portfolio holdings.
Number of Shares
137,085
Previous 162,765
15.78%
Holding current value
$135,714
Previous $172,000
21.51%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ONCY
# of Institutions
43Shares Held
1.31MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL198KShares$196,4160.02% of portfolio
-
Seeds Investor LLC New York, NY190KShares$188,0410.1% of portfolio
-
Morgan Stanley New York, NY139KShares$137,1350.0% of portfolio
-
Goldman Sachs Group Inc New York, NY83.6KShares$82,7620.0% of portfolio
-
Commonwealth Equity Services, LLC63.1KShares$62,4820.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $57.3M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...